Stelara 45 MG/0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FP2ZT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,406
Award facts
- Contract value 100% obligated
- $20,405.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On July 21, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $20,405.94 to AmerisourceBergen Drug Corp for the supply of Stelara 45 mg/0.5 mL syringes. This firm fixed-price delivery order, which is not set-aside, represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier under the DLA's broader medical supply framework. The product will be delivered to the company's Conshohocken, Pennsylvania location, with an ultimate completion date of July 22, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the supply of medications, vaccines, and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has demonstrated extensive capability in meeting federal procurement requirements through competitive award processes. The company's federal contract portfolio encompasses a diverse range of pharmaceutical products and medical supplies supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for Stelara, a specialty immunology medication, exemplifies AmerisourceBergen's role in fulfilling the DLA's medical procurement needs for military and veteran healthcare systems, leveraging the flexibility and comprehensive scope of the underlying indefinite delivery contract.
Quick answers
Who was awarded contract SPE2DB25FP2ZT?
SPE2DB25FP2ZT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 21, 2025.
How much is contract SPE2DB25FP2ZT worth?
The government has obligated $20,406 on SPE2DB25FP2ZT.
Is contract SPE2DB25FP2ZT an order under another contract?
Yes. SPE2DB25FP2ZT is a delivery order under SPE2DB22D3010, an indefinite delivery contract.
Was contract SPE2DB25FP2ZT competed?
The extent of competition for SPE2DB25FP2ZT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award